Hepatitis c and Ammonia decreased

Summary:

Ammonia decreased is found among people with Hepatitis c, especially for people who are male, 50-59 old.

The study analyzes which people have Ammonia decreased with Hepatitis c. It is created by eHealthMe based on reports of 16 people who have Hepatitis c from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hepatitis c?

Hepatitis c is found to be associated with 787 drugs and 984 conditions by eHealthMe. Check the latest studies of Hepatitis c.

What is Ammonia decreased?

Ammonia decreased is found to be associated with 21 drugs and 74 conditions by eHealthMe. Check the latest studies of Ammonia decreased.



On Jul, 19, 2026

16 people who have Hepatitis C and Ammonia Decreased are studied.

Would you have Ammonia decreased when you have Hepatitis c?

Gender of people who have Hepatitis C and experienced Ammonia Decreased *:

  • female: 43.75 %
  • male: 56.25 %

Age of people who have Hepatitis C and experienced Ammonia Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 6.25 %
  • 50-59: 68.75 %
  • 60+: 25.0 %

Common co-existing conditions for these people *:

  1. Seasonal Allergy (allergic condition due to certain season): 1 person, 6.25%
  2. Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 6.25%
  3. Rashes (redness): 1 person, 6.25%
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 6.25%
  5. Nausea And Vomiting: 1 person, 6.25%
  6. Nausea (feeling of having an urge to vomit): 1 person, 6.25%
  7. Joint Pain: 1 person, 6.25%
  8. Insomnia (sleeplessness): 1 person, 6.25%
  9. Headache (pain in head): 1 person, 6.25%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%

Common drugs taken by these people *:

  1. Pantoprazole: 4 people, 25.00%
  2. Copegus: 4 people, 25.00%
  3. Prograf: 4 people, 25.00%
  4. Ribavirin: 3 people, 18.75%
  5. Zepatier: 3 people, 18.75%
  6. Pegasys: 3 people, 18.75%
  7. Selenium: 3 people, 18.75%
  8. Lantus: 2 people, 12.50%
  9. Celexa: 2 people, 12.50%
  10. Lortab: 2 people, 12.50%

Common symptoms for these people *:

  1. Confusional State: 7 people, 43.75%
  2. Memory Loss: 6 people, 37.50%
  3. Encephalopathy (functioning of the brain is affected by some agent or condition): 6 people, 37.50%
  4. Thrombocytopenia (decrease of platelets in blood): 5 people, 31.25%
  5. Haemoglobin Decreased: 5 people, 31.25%
  6. White Blood Cell Count Decreased: 4 people, 25.00%
  7. Blood Glucose Increased: 4 people, 25.00%
  8. Consciousness - Decreased: 4 people, 25.00%
  9. Cytomegalovirus Infection: 4 people, 25.00%
  10. Death: 4 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ammonia decreased?

- Check whether Ammonia decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Ammonia decreased:

All the conditions that are associated with Ammonia decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Ammonia decreased and Hepatitis c, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: